PROTAC AR Degrader-4 TFA liquiritigenin A new pharmacologic action of

A new pharmacologic action of CCI-779 involves FKBP12-independent inhibition of mTOR kinase activity and profound repression of global protein synthesis

InChiKey: HCJXRYXYWPOIGP-UHFFFAOYSA-K

is a potent and selective mTOR inhibitor

While there is a clear pattern of CD4 T cell decline in placebo-gel treated and viral challenged mice

full IC50 determinations is performed for VU0364770 at the MAO-A and MAO-B isoforms

PROTAC AR Degrader-4 TFA liquiritigenin A new pharmacologic action ofPROTAC AR Degrader 4 comprises a cIAP1 ligand binding group, a linker and an androgen receptor (AR) binding group. PROTAC AR Degrader 4 is an AR degrader. Degradation inducers based on cIAP1 are called specific and non genetic IAP dependent protein erasers (SNIPERs) Product information Molecular Weight: 884. 03 Formula: C45H68F3N3O11 Chemical Name: (1S,3aS,3bR,5aS,9aS,9bS,11aS) 9a,11a dimethyl 7 oxo hexadecahydro 1H cyclopenta[a]phenanthren 1 yl 2 [2